Jazz Pharmaceuticals Statistics
Total Valuation
JAZZ has a market cap or net worth of $11.51 billion. The enterprise value is $14.49 billion.
Important Dates
The next estimated earnings date is Tuesday, May 5, 2026, after market close.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
JAZZ has 61.56 million shares outstanding. The number of shares has decreased by -7.61% in one year.
| Current Share Class | 61.56M |
| Shares Outstanding | 61.56M |
| Shares Change (YoY) | -7.61% |
| Shares Change (QoQ) | +2.97% |
| Owned by Insiders (%) | 3.07% |
| Owned by Institutions (%) | 100.45% |
| Float | 59.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 7.81 |
| PS Ratio | 2.70 |
| Forward PS | 2.54 |
| PB Ratio | 2.66 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 8.87 |
| P/OCF Ratio | 8.49 |
| PEG Ratio | 0.14 |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 8.45, with an EV/FCF ratio of 11.17.
| EV / Earnings | n/a |
| EV / Sales | 3.40 |
| EV / EBITDA | 8.45 |
| EV / EBIT | 14.24 |
| EV / FCF | 11.17 |
Financial Position
The company has a current ratio of 1.86, with a Debt / Equity ratio of 1.26.
| Current Ratio | 1.86 |
| Quick Ratio | 1.46 |
| Debt / Equity | 1.26 |
| Debt / EBITDA | 3.11 |
| Debt / FCF | 4.18 |
| Interest Coverage | 3.62 |
Financial Efficiency
Return on equity (ROE) is -8.47% and return on invested capital (ROIC) is 13.90%.
| Return on Equity (ROE) | -8.47% |
| Return on Assets (ROA) | 5.38% |
| Return on Invested Capital (ROIC) | 13.90% |
| Return on Capital Employed (ROCE) | 10.81% |
| Weighted Average Cost of Capital (WACC) | 5.07% |
| Revenue Per Employee | $1.48M |
| Profits Per Employee | -$123,235 |
| Employee Count | 2,890 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 0.79 |
Taxes
| Income Tax | -272.44M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +49.57% in the last 52 weeks. The beta is 0.23, so JAZZ's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | +49.57% |
| 50-Day Moving Average | 177.12 |
| 200-Day Moving Average | 147.45 |
| Relative Strength Index (RSI) | 56.41 |
| Average Volume (20 Days) | 817,785 |
Short Selling Information
The latest short interest is 6.16 million, so 10.01% of the outstanding shares have been sold short.
| Short Interest | 6.16M |
| Short Previous Month | 6.00M |
| Short % of Shares Out | 10.01% |
| Short % of Float | 10.34% |
| Short Ratio (days to cover) | 5.49 |
Income Statement
In the last 12 months, JAZZ had revenue of $4.27 billion and -$356.15 million in losses. Loss per share was -$5.84.
| Revenue | 4.27B |
| Gross Profit | 3.91B |
| Operating Income | 1.02B |
| Pretax Income | -628.59M |
| Net Income | -356.15M |
| EBITDA | 1.71B |
| EBIT | 1.02B |
| Loss Per Share | -$5.84 |
Full Income Statement Balance Sheet
The company has $2.44 billion in cash and $5.43 billion in debt, with a net cash position of -$2.99 billion or -$48.50 per share.
| Cash & Cash Equivalents | 2.44B |
| Total Debt | 5.43B |
| Net Cash | -2.99B |
| Net Cash Per Share | -$48.50 |
| Equity (Book Value) | 4.32B |
| Book Value Per Share | 70.30 |
| Working Capital | 1.92B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $1.36 billion and capital expenditures -$58.75 million, giving a free cash flow of $1.30 billion.
| Operating Cash Flow | 1.36B |
| Capital Expenditures | -58.75M |
| Depreciation & Amortization | 696.30M |
| Net Borrowing | -781.00M |
| Free Cash Flow | 1.30B |
| FCF Per Share | $21.07 |
Full Cash Flow Statement Margins
Gross margin is 91.67%, with operating and profit margins of 23.86% and -8.35%.
| Gross Margin | 91.67% |
| Operating Margin | 23.86% |
| Pretax Margin | -14.73% |
| Profit Margin | -8.35% |
| EBITDA Margin | 40.17% |
| EBIT Margin | 23.86% |
| FCF Margin | 30.39% |
Dividends & Yields
JAZZ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.61% |
| Shareholder Yield | 7.61% |
| Earnings Yield | -3.09% |
| FCF Yield | 11.27% |
Dividend Details Analyst Forecast
The average price target for JAZZ is $216.92, which is 16.03% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $216.92 |
| Price Target Difference | 16.03% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 7.43% |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
JAZZ has an Altman Z-Score of 1.57 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.57 |
| Piotroski F-Score | 5 |